diva of domesticity, was indicted in June on nine charges of obstruction of justice and securities fraud. The charges stem from her December 2001 sale of 3,928 shares of the biotech stock ImClone. She made the trade the day before the FDA announced it had declined to review ImClone's new cancer drug—news that sent shares tumbling. Authorities accuse her of lying to investigators and altering evidence in their investigation. She resigned as CEO of Martha Stewart Omnimedia after the indictment. The charges tarnished her meticulously cultivated image.
Information Please® Database, © 2007 Pearson Education, Inc. All rights reserved.
More on Martha Stewart from Infoplease: